Mustang Bio Valuation
| MBIO Stock | USD 0.20 0.01 4.76% |
Mustang Bio seems to be undervalued based on Macroaxis valuation methodology. Our model forecasts the value of Mustang Bio from analyzing the firm fundamentals such as Shares Owned By Insiders of 5.86 %, current valuation of 7.26 M, and Return On Equity of -11.91 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Mustang Bio's valuation include:
Price Book 31.7451 | Enterprise Value 7.3 M | Enterprise Value Ebitda (0.14) |
Undervalued
Today
Please note that Mustang Bio's price fluctuation is risky at this time. Calculation of the real value of Mustang Bio is based on 3 months time horizon. Increasing Mustang Bio's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Mustang Bio is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Mustang Stock. However, Mustang Bio's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.2 | Real 4.46 | Target 17.25 | Hype 0.19 | Naive 0.21 |
The intrinsic value of Mustang Bio's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Mustang Bio's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Mustang Bio helps investors to forecast how Mustang stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Mustang Bio more accurately as focusing exclusively on Mustang Bio's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Mustang Bio's intrinsic value based on its ongoing forecasts of Mustang Bio's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Mustang Bio's closest peers.
Mustang Bio Cash |
|
Mustang Valuation Trend
Knowing Mustang Bio's actual value is paramount for traders when making sound investment determinations. Using both Mustang Bio's enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
Mustang Bio Total Value Analysis
Mustang Bio is now forecasted to have valuation of 7.26 M with market capitalization of 9.8 M, debt of 2.5 M, and cash on hands of 107.37 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Mustang Bio fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
7.26 M | 9.8 M | 2.5 M | 107.37 M |
Mustang Bio Asset Utilization
One of the ways to look at asset utilization of Mustang is to check how much profit was generated for every dollar of assets it reports. Mustang Bio secures a negative usage of assets of -0.97 %, losing $0.009652 for each dollar of assets held by the firm. Inadequate asset utilization conveys that the company is being less effective with each dollar of assets it secures. Strictly speaking, asset utilization of Mustang Bio shows how discouraging it operates for each dollar spent on its assets.Mustang Bio Ownership Allocation
Mustang Bio maintains a total of 46.93 Million outstanding shares. Mustang Bio secures 5.86 % of its outstanding shares held by insiders and 1.87 % owned by institutional investors. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Mustang Bio Profitability Analysis
Net Loss for the year was (51.6 M) with profit before overhead, payroll, taxes, and interest of 0.About Mustang Bio Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Mustang Bio. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Mustang Bio based exclusively on its fundamental and basic technical indicators. By analyzing Mustang Bio's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Mustang Bio's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Mustang Bio. We calculate exposure to Mustang Bio's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Mustang Bio's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -2.2 M | -2.1 M |
Mustang Bio Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 8.6 M |
Mustang Bio Current Valuation Indicators
Mustang Bio's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Mustang Bio's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Mustang Bio, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Mustang Bio's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Mustang Bio's worth.When determining whether Mustang Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Mustang Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mustang Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mustang Bio Stock: Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mustang Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Mustang Stock, please use our How to Invest in Mustang Bio guide.You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mustang Bio. If investors know Mustang will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mustang Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.33) | Revenue Per Share (0) | Return On Assets (0.97) | Return On Equity (11.91) |
The market value of Mustang Bio is measured differently than its book value, which is the value of Mustang that is recorded on the company's balance sheet. Investors also form their own opinion of Mustang Bio's value that differs from its market value or its book value, called intrinsic value, which is Mustang Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mustang Bio's market value can be influenced by many factors that don't directly affect Mustang Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mustang Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mustang Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mustang Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.